The following pages link to Dose finding in drug development. (Q2488571):
Displaying 23 items.
- Sequential design for binary dose-response experiments (Q301360) (← links)
- A note on confidence bounds after fixed-sequence multiple tests (Q453020) (← links)
- Incorporating a patient dichotomous characteristic in cancer phase I clinical trials using escalation with overdose control (Q454783) (← links)
- Dose finding with escalation with overdose control (EWOC) in cancer clinical trials (Q903293) (← links)
- Pharmacokinetically guided optimum adaptive dose selection in early phase clinical trials (Q1654244) (← links)
- An algorithm based on semidefinite programming for finding minimax optimal designs (Q1662093) (← links)
- Bayesian learning of dose-response parameters from a cohort under response-guided dosing (Q1681360) (← links)
- Escalation with overdose control using ordinal toxicity grades for cancer phase I clinical trials (Q1929691) (← links)
- Number of patients per cohort and sample size considerations using dose escalation with overdose control (Q1929695) (← links)
- Modeling intracellular delay in within-host HIV dynamics under conditioning of drugs of abuse (Q2035800) (← links)
- A comparative study of the dose-response analysis with application to the target dose estimation (Q2323265) (← links)
- Cumulative cohort design for dose-finding (Q2455719) (← links)
- Exact simultaneous confidence bands for quadratic and cubic polynomial regression with applications in dose response study (Q2803539) (← links)
- Efficient algorithms for optimal designs with correlated observations in pharmacokinetics and dose-finding studies (Q2893997) (← links)
- A Latent Contingency Table Approach to Dose Finding for Combinations of Two Agents (Q3183236) (← links)
- Testing effect of a drug using multiple nested models for the dose–response (Q3459939) (← links)
- Sequential Designs for Dose Escalation Studies in Oncology (Q4905910) (← links)
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers (Q5450494) (← links)
- The Tukey trend test: Multiplicity adjustment using multiple marginal models (Q6055568) (← links)
- Exact simultaneous confidence intervals for logical selection of a biomarker cut‐point (Q6068466) (← links)
- Optimal dose‐finding for efficacy–safety models (Q6070996) (← links)
- Performance Measures in Dose‐Finding Experiments (Q6085864) (← links)
- Model selection characteristics when using MCP‐Mod for dose–response gene expression data (Q6089914) (← links)
